METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.

BACKGROUND: METTL3 is known to be involved in all stages in the life cycle of RNA. It affects the tumor formation by the regulation the m6A modification in the mRNAs of critical oncogenes or tumor suppressors. In bladder cancer, METTL3 could promote the bladder cancer progression via AFF4/NF-κB/MYC signaling network by an m6A dependent manner. Recently, METTL3 was also found to affect the m6A modification in non-coding RNAs including miRNAs, lincRNAs and circRNAs. However, whether this mechanism is related to the proliferation of tumors induced by METTL3 is not reported yet. METHODS: Quantitative real-time PCR, western blot and immunohistochemistry were used to detect the expression of METTL3 in bladder cancer. The survival analysis was adopted to explore the association between METTL3 expression and the prognosis of bladder cancer. Bladder cancer cells were stably transfected with lentivirus and cell proliferation and cell cycle, as well as tumorigenesis in nude mice were performed to assess the effect of METTL3 in bladder cancer. RNA immunoprecipitation (RIP), co-immunoprecipitations and RNA m6A dot blot assays were conducted to confirm that METTL3 interacted with the microprocessor protein DGCR8 and modulated the pri-miR221/222 process in an m6A-dependent manner. Luciferase reporter assay was employed to identify the direct binding sites of miR221/222 with PTEN. Colony formation assay and CCK8 assays were conducted to confirm the function of miR-221/222 in METTL3-induced cell growth in bladder cancer. RESULTS: We confirmed the oncogenic role of METTL3 in bladder cancer by accelerating the maturation of pri-miR221/222, resulting in the reduction of PTEN, which ultimately leads to the proliferation of bladder cancer. Moreover, we found that METTL3 was significantly increased in bladder cancer and correlated with poor prognosis of bladder cancer patients. CONCLUSIONS: Our findings suggested that METTL3 may have an oncogenic role in bladder cancer through interacting with the microprocessor protein DGCR8 and positively modulating the pri-miR221/222 process in an m6A-dependent manner. To our knowledge, this is the first comprehensive study that METTL3 affected the tumor formation by the regulation the m6A modification in non-coding RNAs, which might provide fresh insights into bladder cancer therapy.

Epitaxial Growth of Honeycomb Monolayer CuSe with Dirac Nodal Line Fermions.

2D transition metal chalcogenides have attracted tremendous attention due to their novel properties and potential applications. Although 2D transition metal dichalcogenides are easily fabricated due to their layer-stacked bulk phase, 2D transition metal monochalcogenides are difficult to obtain. Recently, a single atomic layer transition metal monochalcogenide (CuSe) with an intrinsic pattern of nanoscale triangular holes is fabricated on Cu(111). The first-principles calculations show that free-standing monolayer CuSe with holes is not stable, while hole-free CuSe is endowed with the Dirac nodal line fermion (DNLF), protected by mirror reflection symmetry. This very rare DNLF state is evidenced by topologically nontrivial edge states situated inside the spin-orbit coupling gaps. Motivated by the promising properties of hole-free honeycomb CuSe, monolayer CuSe is fabricated on Cu(111) surfaces by molecular beam epitaxy and confirmed success with high resolution scanning tunneling microscopy. The good agreement of angle resolved photoemission spectra with the calculated band structures of CuSe/Cu(111) demonstrates that the sample is monolayer CuSe with a honeycomb lattice. These results suggest that the honeycomb monolayer transition metal monochalcogenide can be a new platform to study 2D DNLFs.